Édina Poletto

591 total citations
38 papers, 410 citations indexed

About

Édina Poletto is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Édina Poletto has authored 38 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 16 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Édina Poletto's work include Lysosomal Storage Disorders Research (24 papers), CRISPR and Genetic Engineering (12 papers) and RNA Interference and Gene Delivery (9 papers). Édina Poletto is often cited by papers focused on Lysosomal Storage Disorders Research (24 papers), CRISPR and Genetic Engineering (12 papers) and RNA Interference and Gene Delivery (9 papers). Édina Poletto collaborates with scholars based in Brazil, United States and Australia. Édina Poletto's co-authors include Guilherme Baldo, Úrsula da Silveira Matte, Roberto Giugliani, Natalia Gomez‐Ospina, Roselena Silvestri Schuh, Gabriela Pasqualim, Hélder Ferreira Teixeira, Esteban Alberto Gonzalez, Ângela Maria Vicente Tavares and Pasqualina Colella and has published in prestigious journals such as Nature Communications, Advanced Drug Delivery Reviews and International Journal of Molecular Sciences.

In The Last Decade

Édina Poletto

34 papers receiving 405 citations

Peers

Countries citing papers authored by Édina Poletto

Since Specialization

Citations

This map shows the geographic impact of Édina Poletto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Édina Poletto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Édina Poletto more than expected).

Fields of papers citing papers by Édina Poletto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Édina Poletto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Édina Poletto. The network helps show where Édina Poletto may publish in the future.

Co-authorship network of co-authors of Édina Poletto

This figure shows the co-authorship network connecting the top 25 collaborators of Édina Poletto. A scholar is included among the top collaborators of Édina Poletto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Édina Poletto. Édina Poletto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model 2024 ·Cell Biochemistry and Function ·(unknown), Édina Poletto, (unknown), Carlos Eduardo Diaz Jacques, Priscila Vianna, Luiza Steffens Reinhardt, Guilherme Baldo, Carmen Regla Vargas	0
2	Laronidase-loaded liposomes reach the brain and other hard-to-treat organs after noninvasive nasal administration 2024 ·International Journal of Pharmaceutics ·Roselena Silvestri Schuh, (unknown), (unknown), Flávia Nathiely Silveira Fachel, Édina Poletto, (unknown), (unknown), (unknown), (unknown), Ana Helena da Rosa Paz, Guilherme Baldo, Úrsula da Silveira Matte, (unknown), Hélder Ferreira Teixeira	3
3	Basic and translational research in rare diseases in low- and middle-income countries: challenges and solutions 2024 ·Journal of Community Genetics ·Graziella Rodrigues, Édina Poletto, Filippo Pinto e Vairo, Guilherme Baldo	0
4	Pilot Study of Newborn Screening for Six Lysosomal Diseases in Brazil 2023 ·SSRN Electronic Journal ·Francyne Kubaski, Inês Sousa, (unknown), (unknown), Camilo Silva, (unknown), Ana Carolina Brusius‐Facchin, (unknown), (unknown), Filippo Pinto e Vairo, Édina Poletto, (unknown), (unknown), Enzo Ranieri, Giulia Polo, Xinying Hong, (unknown), Alberto Burlina, Michael H. Gelb, Roberto Giugliani	1
5	Pilot study of newborn screening for six lysosomal diseases in Brazil 2023 ·Molecular Genetics and Metabolism ·Francyne Kubaski, Inês Sousa, (unknown), (unknown), Camilo Silva, (unknown), Ana Carolina Brusius‐Facchin, (unknown), (unknown), Filippo Pinto e Vairo, Édina Poletto, (unknown), (unknown), Enzo Ranieri, Giulia Polo, Xinying Hong, (unknown), Alberto Burlina, Michael H. Gelb, Roberto Giugliani	9
6	Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C 2022 ·International Journal of Neonatal Screening ·Francyne Kubaski, Alberto Burlina, Giulia Polo, Danilo Florentino Pereira, (unknown), Camilo Silva, (unknown), Kristiane Michelin‐Tirelli, (unknown), Maira Graeff Burin, Ana Carolina Brusius‐Facchin, (unknown), Larissa Faqueti, Gabrielle D. Iop, Édina Poletto, Roberto Giugliani	2
7	Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses 2022 ·Advanced Drug Delivery Reviews ·Flávia Nathiely Silveira Fachel, (unknown), Édina Poletto, Roselena Silvestri Schuh, Hélder Ferreira Teixeira, Roberto Giugliani, Guilherme Baldo, Úrsula da Silveira Matte	7
8	Biochemical diagnosis of aromatic-L-amino acid decarboxylase deficiency (AADCD) by assay of AADC activity in plasma using liquid chromatography/tandem mass spectrometry 2022 ·Molecular Genetics and Metabolism Reports ·(unknown), Francyne Kubaski, (unknown), Gabriel Rübensam, (unknown), Camilo Silva, (unknown), Édina Poletto, Larissa Faqueti, (unknown), (unknown), Vanessa van der Linden, Hélio van der Linden, Charles Marques Lourenço, Roberto Giugliani	3
9	Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation 2022 ·Molecular Therapy — Methods & Clinical Development ·Édina Poletto, Pasqualina Colella, (unknown), Shaukat Khan, Shunji Tomatsu, Guilherme Baldo, Natalia Gomez‐Ospina	12
10	Evaluation of oxidative stress and mitochondrial function in a type II mucopolysaccharidosis cellular model: in vitro effects of genistein and coenzyme Q10 2022 ·Metabolic Brain Disease ·Carlos Eduardo Diaz Jacques, (unknown), Édina Poletto, (unknown), Priscila Vianna, Luiza Steffens Reinhardt, Guilherme Baldo, Carmen Regla Vargas	7
11	Genome editing in mucopolysaccharidoses and mucolipidoses 2021 ·Progress in molecular biology and translational science ·(unknown), Édina Poletto, Roselena Silvestri Schuh, Úrsula da Silveira Matte, Guilherme Baldo	2
12	Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing 2020 ·Nature Communications ·(unknown), Édina Poletto, (unknown), Pasqualina Colella, (unknown), Thomas J. Montine, Matthew H. Porteus, Natalia Gomez‐Ospina	38
13	Evidence for inflammasome activation in the brain of mucopolysaccharidosis type II mice 2020 ·Metabolic Brain Disease ·(unknown), (unknown), Esteban Alberto Gonzalez, Édina Poletto, (unknown), Úrsula da Silveira Matte, Roberto Giugliani, Guilherme Baldo	11
14	Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice 2019 ·Gene Therapy ·Roselena Silvestri Schuh, Esteban Alberto Gonzalez, Ângela Maria Vicente Tavares, (unknown), (unknown), (unknown), Francyne Kubaski, Édina Poletto, Roberto Giugliani, Hélder Ferreira Teixeira, Úrsula da Silveira Matte, Guilherme Baldo	28
15	Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice 2018 ·International Journal of Pharmaceutics ·Juliana Bidone, Roselena Silvestri Schuh, (unknown), Édina Poletto, Gabriela Pasqualim, (unknown), (unknown), Ricardo Machado Xavier, Guilherme Baldo, Hélder Ferreira Teixeira, Úrsula da Silveira Matte	10
16	Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology 2018 ·Journal of Colloid and Interface Science ·Roselena Silvestri Schuh, Édina Poletto, Flávia Nathiely Silveira Fachel, Úrsula da Silveira Matte, Guilherme Baldo, Hélder Ferreira Teixeira	17
17	In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system 2018 ·Journal of Controlled Release ·Roselena Silvestri Schuh, Édina Poletto, Gabriela Pasqualim, Ângela Maria Vicente Tavares, (unknown), Esteban Alberto Gonzalez, (unknown), Úrsula da Silveira Matte, Hélder Ferreira Teixeira, Guilherme Baldo	55
18	Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy 2018 ·Pharmaceutical Research ·Roselena Silvestri Schuh, Juliana Bidone, Édina Poletto, (unknown), Gabriela Pasqualim, Talita Giacomet de Carvalho, (unknown), (unknown), Ricardo Machado Xavier, Guilherme Baldo, Úrsula da Silveira Matte, Hélder Ferreira Teixeira	24
19	Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice 2018 ·Life Sciences ·Esteban Alberto Gonzalez, (unknown), Ângela Maria Vicente Tavares, (unknown), Édina Poletto, Roberto Giugliani, Úrsula da Silveira Matte, Guilherme Baldo	27
20	Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity 2017 ·Cardiovascular Pathology ·Guilherme Baldo, Ângela Maria Vicente Tavares, Esteban Alberto Gonzalez, Édina Poletto, Fabiana Quoos Mayer, Úrsula da Silveira Matte, Roberto Giugliani	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact